NCT00177268Recruiting

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

University of Pittsburgh

Start Date

10/1/2004

Completion Date

1/1/2032

Summary

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

Detailed Description

The purpose of this study is to provide a central mechanism for monitoring access to peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis patients to monitor: * immunologic assays/flow cytometry * tumor progression/regression * genomic studies * proteomic studies * others germane to the advancement of CTCL treatment

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * 18 or older * able and willing to provide informed consent * diagnosed with CTCL * diagnosed with either atopic dermatitis or eczema Exclusion Criteria: * Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record

Interventions

OTHER

Blood draw, skin biopsy or urine collection

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Cutaneous T-cell LymphomaSezary SyndromeMycosis FungoidesEczemaAtopic Dermatitis

Locations

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania 15213

United States